Fresenius Medical Care Ag (FMS) Stock Forecast Oct. 16, 2026
Analysis updated on Oct. 16, 2026 (UTC) · Alpha · vs marketSwitch to Total · NYSE
Fresenius Medical Care Ag (FMS) stock forecast summary
Our AI ranks Fresenius Medical Care Ag outside the neutral middle of its coverage (a directional signal). Create a free account and follow it to see the exact price target.
Fresenius Medical Care Ag is a large-cap company with a market capitalization of $12.85B. It ranks number 1 by market capitalization among the 13 Services-Misc Health & Allied Services, NEC issuers in our coverage with a current forecast.
For FMS, the Spearman rank correlation between our 90-day forecasts and the returns that followed is 23.0%, measured on 357 forecast dates between 2022-07-29 and 2026-07-17 on this stock's own recent history. A rank correlation runs from -100% to +100%: it measures whether higher forecasts were followed by higher returns, and a value near zero or below means the model has shown little skill on this stock. On the 30-day forecasts the same correlation is 28.0%, measured on 400 forecast dates between 2022-07-29 and 2026-09-16. Across our coverage, the out-of-sample test on 4495 stocks from 2025-01-06 to 2026-07-07 produced a positive net return in 82.5% of rebalance periods (factor-neutral book, net of estimated costs). Full backtest report
Expected return relative to the market over the horizon: a positive alpha means the model expects the stock to beat the market, whatever the market does. Ratings: strong buy ≥ +1.8%, buy ≥ +0.2%, sell < -0.9%, strong sell < -1.2% (top 15%, next 20%, middle 30%, next 20%, bottom 15% of the 2026-10-16 signals)
A free account shows the exact forecast, rating and rank of 3 tickers you follow, FMS included.
Follow FMS freeFMS price chart and AI forecast
How FMS ranks among 5171 stocks
90D Alpha forecasts of every company scored, cut into five relative ratings at the 15th, 35th, 65th and 85th percentiles (dashed lines).
Fresenius Medical Care Ag (FMS) fundamentals
Trailing twelve months. The industry median and the rank (1 = highest) are taken over the Services-Misc Health & Allied Services, NEC peers listed below that report each metric.
Valuation & Market
| Metric | FMS | Rank |
|---|---|---|
| Market Cap | $12.85B | 1/13 |
| Revenue/Share | $58.96 | – |
Profitability & Margins
| Metric | FMS | Rank |
|---|---|---|
| ROE | 12.2% | 3/7 |
| Net Margin | 4.8% | 6/10 |
Financial Health
| Metric | FMS | Rank |
|---|---|---|
| D/E Ratio | 1.26x | 4/10 |
| Interest Coverage | 7.4x | 4/12 |
Income Statement
| Metric | FMS | Rank |
|---|---|---|
| Total Revenue | $34.19B | 1/10 |
| Net Income | $1.63B | 1/10 |
Dividend & Shareholder Information
| Metric | FMS | Rank |
|---|---|---|
| Shares Outstanding | 580M | – |
| Net Income Growth | 61.5% | 2/6 |
Balance Sheet Highlights (USD millions)
| Total Liabilities | $16.72B |
FMS quarterly financials and insider trading
Fresenius Medical Care Ag (FMS) industry peers
Companies classified under the same SEC industry code as Fresenius Medical Care Ag (Services-Misc Health & Allied Services, NEC): 13 common-stock issuers with a forecast this week, one row per issuer, largest first. This is a classification match, not a curated list of competitors.
Reveal all forecasts · See exact % predictions for all competitors
Sign up free| Company | 90-Day AI Forecast (Alpha) | Market Cap |
|---|---|---|
| FMS Fresenius Medical Care Ag | ▼ | $12.85B |
| DVA Davita Inc. | ▶ | $11.95B |
| SHC Sotera Health Co | ▼ | $5.16B |
| PGNY Progyny, Inc. | ▼ | $2.11B |
| AGL Agilon Health, Inc. | ▲ | $1.43B |
| VMD Viemed Healthcare, Inc. | ▼ | $371M |
| PARK Park Dental Partners, Inc. | ▲ | $91M |
| MRAI Marpai, Inc. | ▶ | $85M |
| CCEL Cryo Cell International Inc | ▲ | $29M |
| PFHO Pacific Health Care Organization Inc | ▲ | $12M |
| MGRX Mangoceuticals, Inc. | ▲ | $7M |
| NIVF Newgenivf Group Ltd | ▼ | $2M |
| BRTX Biorestorative Therapies, Inc. | ▶ | $2M |
Where FMS sits on the market map
Fresenius Medical Care Ag (FMS) stock news
Loading...
Fresenius Medical Care Ag (FMS) stock forecast FAQ
What is the Fresenius Medical Care Ag (FMS) stock forecast?
Our AI ranks Fresenius Medical Care Ag outside the neutral middle of its coverage (a directional signal). Create a free account and follow it to see the exact price target.
How accurate are Fresenius Medical Care Ag stock predictions?
For FMS, the Spearman rank correlation between our 90-day forecasts and the returns that followed is 23.0%, measured on 357 forecast dates between 2022-07-29 and 2026-07-17 on this stock's own recent history. A rank correlation runs from -100% to +100%: it measures whether higher forecasts were followed by higher returns, and a value near zero or below means the model has shown little skill on this stock. On the 30-day forecasts the same correlation is 28.0%, measured on 400 forecast dates between 2022-07-29 and 2026-09-16. Across our coverage, the out-of-sample test on 4495 stocks from 2025-01-06 to 2026-07-07 produced a positive net return in 82.5% of rebalance periods (factor-neutral book, net of estimated costs). Full backtest report
How often are Fresenius Medical Care Ag forecasts updated?
Fresenius Medical Care Ag forecasts are refreshed on trading days as the daily model run completes. The forecast on this page was produced on Oct. 16, 2026.
Which companies are Fresenius Medical Care Ag's industry peers?
13 issuers in our coverage, FMS included, share the SEC industry code Services-Misc Health & Allied Services, NEC. The largest are: Davita Inc. (DVA), Sotera Health Co (SHC), Progyny, Inc. (PGNY), Agilon Health, Inc. (AGL), Viemed Healthcare, Inc. (VMD), Park Dental Partners, Inc. (PARK).
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.